David Sidransky Selected Research

COOH-terminal signal transamidase

8/2008	Profiling the expression pattern of GPI transamidase complex subunits in human cancer.
11/2007	Alterations of GPI transamidase subunits in head and neck squamous carcinoma.
10/2006	Overexpression of glycosylphosphatidylinositol (GPI) transamidase subunits phosphatidylinositol glycan class T and/or GPI anchor attachment 1 induces tumorigenesis and contributes to invasion in human breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Sidransky Research Topics

Disease

196	Neoplasms (Cancer) 01/2022 - 01/2002
53	Squamous Cell Carcinoma of Head and Neck 01/2021 - 09/2003
31	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2002
26	Carcinogenesis 01/2021 - 03/2002
26	Head and Neck Neoplasms (Head and Neck Cancer) 01/2019 - 05/2002
22	Carcinoma (Carcinomatosis) 01/2020 - 01/2002
17	Breast Neoplasms (Breast Cancer) 01/2018 - 03/2004
14	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 01/2005
13	Prostatic Neoplasms (Prostate Cancer) 07/2012 - 09/2002
12	Urinary Bladder Neoplasms (Bladder Cancer) 01/2015 - 03/2002
11	Esophageal Squamous Cell Carcinoma 01/2020 - 12/2002
7	Adenocarcinoma 01/2022 - 12/2002
7	Neoplasm Metastasis (Metastasis) 01/2022 - 08/2004
7	Stomach Neoplasms (Stomach Cancer) 01/2022 - 04/2006
7	Colorectal Neoplasms (Colorectal Cancer) 01/2015 - 10/2003
7	Thyroid Neoplasms (Thyroid Cancer) 07/2012 - 03/2003
7	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2010 - 05/2002
6	Mouth Neoplasms (Oral Cancer) 09/2021 - 01/2015
6	Margins of Excision 01/2020 - 04/2004
5	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 07/2003
5	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2016 - 01/2002
5	Papillary Thyroid Cancer 12/2007 - 04/2003
4	Gallbladder Neoplasms (Gallbladder Cancer) 06/2019 - 11/2004
4	Colonic Neoplasms (Colon Cancer) 08/2011 - 03/2008
4	Mitochondrial Diseases (Mitochondrial Disease) 09/2010 - 10/2003
4	Melanoma (Melanoma, Malignant) 12/2007 - 07/2003
3	Disease Progression 12/2018 - 06/2002
3	Brain Neoplasms (Brain Tumor) 01/2018 - 08/2009
3	Squamous Cell Neoplasms (Squamous Cell Cancer) 04/2017 - 02/2006
3	Infections 01/2016 - 01/2013
3	Pancreatic Neoplasms (Pancreatic Cancer) 07/2014 - 03/2008
3	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 08/2004 - 01/2002
2	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 12/2015
2	Wounds and Injuries (Trauma) 01/2020 - 06/2011

Drug/Important Bio-Agent (IBA)

79	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2002
49	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2005
36	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2002
26	Mitochondrial DNA (mtDNA)IBA 01/2020 - 01/2002
16	SmokeIBA 01/2021 - 03/2005
14	Biological ProductsIBA 01/2020 - 05/2003
13	Messenger RNA (mRNA)IBA 01/2020 - 03/2002
13	hydrogen sulfite (bisulfite)IBA 05/2014 - 05/2003
10	Phosphotransferases (Kinase)IBA 11/2021 - 11/2004
10	Cisplatin (Platino)FDA LinkGeneric 04/2017 - 10/2004
9	ErbB Receptors (EGF Receptor)IBA 01/2021 - 04/2004
8	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 01/2011
8	Decitabine FDA Link 04/2013 - 12/2002
7	NucleotidesIBA 01/2018 - 04/2003
7	MicroRNAs (MicroRNA)IBA 01/2018 - 12/2008
7	Small Interfering RNA (siRNA)IBA 09/2017 - 09/2008
7	Pharmaceutical PreparationsIBA 07/2017 - 10/2006
6	Transcription Factors (Transcription Factor)IBA 01/2018 - 10/2004
6	Cetuximab (Erbitux)FDA Link 09/2017 - 04/2012
5	EnzymesIBA 09/2021 - 05/2002
5	Protein Isoforms (Isoforms)IBA 01/2020 - 05/2005
5	ChromatinIBA 01/2020 - 07/2011
5	RNA (Ribonucleic Acid)IBA 12/2017 - 10/2003
5	Adenine FDA LinkGeneric 07/2005 - 04/2003
5	ThymineIBA 07/2005 - 04/2003
4	Cell-Free Nucleic AcidsIBA 01/2020 - 12/2006
4	Genetic Markers (Genetic Marker)IBA 11/2017 - 05/2003
4	Paclitaxel (Taxol)FDA LinkGeneric 07/2017 - 01/2011
4	PlatinumIBA 07/2017 - 10/2005
4	Tumor Biomarkers (Tumor Markers)IBA 08/2008 - 01/2002
4	Aquaporins (Water Channels)IBA 08/2008 - 10/2003
3	Tyrosine (L-Tyrosine)FDA Link 01/2022 - 10/2016
3	ParaffinIBA 09/2021 - 03/2003
3	Formaldehyde (Formol)FDA Link 09/2021 - 07/2003
3	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2013
3	LigandsIBA 01/2018 - 03/2002
3	ranpirnase (Pannon)IBA 01/2017 - 01/2005
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2016 - 01/2013
3	Cysteine Dioxygenase (Dioxygenase, Cysteine)IBA 01/2016 - 01/2012
3	Prostate-Specific Antigen (Semenogelase)IBA 11/2014 - 12/2005
3	tacrolimus binding protein 4 (FKBP52)IBA 08/2014 - 02/2009
3	OligonucleotidesIBA 02/2014 - 03/2002
3	AntigensIBA 01/2012 - 02/2011
3	Antineoplastic Agents (Antineoplastics)IBA 01/2011 - 08/2009
3	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 09/2010 - 04/2005
3	Peptides (Polypeptides)IBA 02/2010 - 09/2004
3	COOH-terminal signal transamidaseIBA 08/2008 - 10/2006
3	Aquaporin 5IBA 08/2008 - 03/2008
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2007 - 04/2006
3	trichostatin A (A 300)IBA 11/2007 - 12/2002
3	Death-Associated Protein KinasesIBA 08/2007 - 04/2003
2	CyclinsIBA 11/2021 - 11/2006
2	Glucose (Dextrose)FDA LinkGeneric 09/2021 - 01/2012
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021 - 08/2006
2	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2021 - 01/2018
2	Histones (Histone)IBA 01/2020 - 12/2017
2	Antiviral Agents (Antivirals)IBA 01/2020 - 01/2016
2	Immune Checkpoint InhibitorsIBA 01/2019 - 01/2018
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 08/2018 - 04/2011
2	Progesterone FDA LinkGeneric 01/2018 - 01/2017
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2018 - 10/2017

Therapy/Procedure

34	Therapeutics 01/2021 - 05/2003
12	Drug Therapy (Chemotherapy) 01/2021 - 10/2005
4	Radiotherapy 01/2022 - 10/2014
4	Prostatectomy (Retropubic Prostatectomy) 11/2014 - 12/2005
3	Precision Medicine 01/2020 - 11/2008